Kaitlin M. Woo

Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy

Jarushka Naidoo, Xuan Wang, Kaitlin M. Woo et al. · Journal of Clinical Oncology · 2016 · 1.2K citations · Full text

Medicine, Oncology, Pathology +17

Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center

Troy Z. Horvat, Nelly G. Adel, Thu-Oanh Dang et al. · Journal of Clinical Oncology · 2015 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

M. Catherine Pietanza, Saiama N. Waqar, Lee M. Krug et al. · Journal of Clinical Oncology · 2018 · 398 citations · Full text

Medicine, Oncology, Pharmacology +13

Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer

Hao‐Xian Yang, Kaitlin M. Woo, Camelia S. Sima et al. · Annals of Surgery · 2016 · 335 citations

Medicine, Oncology, Surgery +17

The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers

Hideki Ujiie, Kyuichi Kadota, Jun‐ichi Nitadori et al. · OncoImmunology · 2015 · 134 citations · Full text

Medicine, Oncology, Immunopathology +4